Home › Companies › Fennec Pharmaceuticals Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Fennec Pharmaceuticals Inc.’s Form 8-K, filed 2026-06-10 (Item 5.07 on EDGAR). Page generated 04 October 2026.
Proxy season: 2025-2026
Explore Fennec Pharmaceuticals Inc. in the interactive database Compare manager voting policies
These tallies are Fennec Pharmaceuticals Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-10 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Dr. Khalid Islam | 20,246,596 | -- | -- | 126,891 | 5,881,885 | Majority: yes |
| Elect Director: Chris A. Rallis | 20,126,058 | -- | -- | 247,429 | 5,881,885 | Majority: yes |
| Elect Director: Marco Brughera | 20,237,230 | -- | -- | 136,257 | 5,881,885 | Majority: yes |
| Elect Director: Jodi Cook | 20,191,538 | -- | -- | 181,949 | 5,881,885 | Majority: yes |
| Elect Director: Jeffrey Hackman | 20,282,707 | -- | -- | 90,780 | 5,881,885 | Majority: yes |
| Proposal 2: The resolution to appoint Haskell & White LLP as independent public accounting firm of the Company and to authorize the Board of Directors to fix their remuneration was approved based on the following vote: | 26,091,716 | 29,165 | -- | 134,491 | 0 | Passed |
| Proposal 3: The resolution to vote on the advisory vote on executive compensation was approved based on the following vote: | 19,326,750 | 336,060 | 710,677 | -- | 5,881,885 | Passed |
| Proposal 4: The resolution to vote on the advisory vote on the frequency of advisory votes on compensation of Corporations named executive officers was approved based on the following vote: | 2,086,219 | -- | 49,294 | -- | -- | Passed |
| Proposal 5: The resolution to approve certain amendments to Corporation's 2020 Equity Incentive Plan was approved based on the following vote: | 17,425,439 | 1,429,951 | 751,944 | -- | 5,881,885 | Passed |
| Proposal 6: The resolution to ratify and approve the adoption of Fennec's 2026 Equity Inducement Plan was approved based on the following vote:. | 18,626,207 | 1,033,779 | 713,501 | -- | 5,881,885 | Passed |
Source: Fennec Pharmaceuticals Inc., Form 8-K, filed with the SEC on 2026-06-10 — read the filing on EDGAR.
Each item below shows how the 102 asset managers that disclosed a Fennec Pharmaceuticals Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Fennec Pharmaceuticals Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 7 wordings of this item as funds reported it.
— Passed · no against or withheld count reported
Fennec Pharmaceuticals Inc.’s own tally for this item (“Proposal 4: The resolution to vote on the advisory vote on the frequency of advisory votes on compensation of Corporations named executive officers was approved based on the following vote:”): 2,086,219 for; no against or withheld count reported — passed, per its Form 8-K filed 2026-06-10 (Item 5.07).
The 101 asset managers below cast 97% of the shares they voted on this item FOR (12,727 for, 348 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Southpoint Capital Advisors LP | 0 | 0 | 0 | 0 | 1 Year |
| Solas Capital Management, LLC | 0 | 0 | 0 | 0 | One Year |
| AIGH Capital Management LLC | 0 | 0 | 0 | 0 | 3 |
| Vanguard | 0 | 0 | 0 | 0 | One Year |
| BlackRock | 0 | 0 | 0 | 0 | 1 Year |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | One Year |
| Fidelity | 0 | 0 | 0 | 0 | One Year |
| State Street | 0 | 0 | 0 | 0 | One Year |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 0 | 0 | 0 | One Year |
| Charles Schwab | 0 | 0 | 0 | 0 | 1 Year |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | One Year |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | One Year |
| Northern Trust | 0 | 0 | 0 | 0 | 1 Year |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | One Year |
| THOMPSON SIEGEL & WALMSLEY LLC | 0 | 0 | 0 | 0 | One Year |
| Citadel | 0 | 0 | 0 | 0 | One Year |
| 1492 Capital Management LLC | 0 | 0 | 0 | 0 | 1 Year |
| STATE OF WISCONSIN INVESTMENT BOARD | 0 | 0 | 0 | 0 | One Year |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | 1 Year |
| T. Rowe Price | 0 | 0 | 0 | 0 | One Year |
| Invesco | 0 | 0 | 0 | 0 | One Year |
| Eleva Capital SAS | 0 | 0 | 0 | 0 | One Year |
| Nuveen | 0 | 0 | 0 | 0 | One Year |
| Edward D. Jones & Co., L.P. | 0 | 0 | 0 | 0 | 1 Year |
| TIAA | 0 | 0 | 0 | 0 | One Year |
Showing the 25 largest of 101 asset managers. See all 101 in the interactive database.
Combines 3 wordings of this item as funds reported it.
97% fund support · no official result
The 84 asset managers below cast 97% of the shares they voted on this item FOR (8,997,998 for, 256,503 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Southpoint Capital Advisors LP | 2,744,741 | 0 | 0 | 0 | For |
| Solas Capital Management, LLC | 2,482,198 | 0 | 0 | 0 | For |
| Vanguard | 1,098,186 | 0 | 0 | 0 | For |
| BlackRock | 910,003 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 375,679 | 0 | 0 | 0 | For |
| Fidelity | 343,899 | 0 | 0 | 0 | For |
| State Street | 209,133 | 2,725 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 149,763 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 108,005 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 108,005 | 0 | 0 | Against |
| Northern Trust | 88,975 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 67,012 | 0 | 0 | 0 | For |
| THOMPSON SIEGEL & WALMSLEY LLC | 57,226 | 0 | 0 | 0 | For |
| Citadel | 52,171 | 0 | 0 | 0 | For |
| 1492 Capital Management LLC | 50,705 | 0 | 0 | 0 | For |
| STATE OF WISCONSIN INVESTMENT BOARD | 39,100 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 33,481 | 0 | 0 | 0 | For |
| T. Rowe Price | 27,840 | 0 | 0 | 0 | For |
| Invesco | 0 | 26,100 | 0 | 0 | Against |
| Nuveen | 24,538 | 0 | 0 | 0 | For |
| Edward D. Jones & Co., L.P. | 24,312 | 0 | 0 | 0 | For |
| TIAA | 23,524 | 0 | 0 | 0 | For |
| Equitable | 18,866 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,300 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,112 | 0 | 0 | 0 | For |
Showing the 25 largest of 84 asset managers. See all 84 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.8% Passed · of votes cast
Fennec Pharmaceuticals Inc.’s own tally for this item (“Proposal 2: The resolution to appoint Haskell & White LLP as independent public accounting firm of the Company and to authorize the Board of Directors to fix their remuneration was approved based on the following vote:”): 26,091,716 for, 29,165 against — passed, per its Form 8-K filed 2026-06-10 (Item 5.07). Of all 34,737,030 outstanding shares: 75% for, 0.1% against (75% of the company cast a for/against vote).
The 34 asset managers below cast 100% of the shares they voted on this item FOR (2,369,541 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,052,649 | 0 | 0 | 0 | For |
| BlackRock | 572,407 | 0 | 0 | 0 | For |
| Fidelity | 337,719 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 108,005 | 0 | 0 | 0 | For |
| Charles Schwab | 63,537 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 33,481 | 0 | 0 | 0 | For |
| Eleva Capital SAS | 24,960 | 0 | 0 | 0 | For |
| TIAA | 23,524 | 0 | 0 | 0 | For |
| Equitable | 18,866 | 0 | 0 | 0 | For |
| Invesco | 17,995 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,300 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,112 | 0 | 0 | 0 | For |
| Global X | 13,761 | 0 | 0 | 0 | For |
| Pacific Life | 10,772 | 0 | 0 | 0 | For |
| GPS Funds I | 9,445 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,442 | 0 | 0 | 0 | For |
| Brighthouse | 7,920 | 0 | 0 | 0 | For |
| John Hancock | 5,678 | 0 | 0 | 0 | For |
| ProShares | 4,388 | 0 | 0 | 0 | For |
| Voya | 4,320 | 0 | 0 | 0 | For |
| DWS | 4,135 | 0 | 0 | 0 | For |
| State Street | 2,673 | 0 | 0 | 0 | For |
| Nationwide | 2,206 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 1,942 | 0 | 0 | 0 | For |
| SEI | 1,800 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Fennec Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Jodi Cook”): 20,191,538 for, 181,949 withheld, per its Form 8-K filed 2026-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 34,737,030 outstanding shares: 58% for, 0.6% withheld (59% of the company cast a for/withheld vote).
The 34 asset managers below cast 100% of the shares they voted on this item FOR (2,327,015 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,052,649 | 0 | 0 | 0 | For |
| BlackRock | 572,407 | 0 | 0 | 0 | For |
| Fidelity | 337,719 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 108,005 | 0 | 0 | 0 | For |
| Charles Schwab | 63,537 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 33,481 | 0 | 0 | 0 | For |
| Eleva Capital SAS | 24,960 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 23,524 | 0 | Abstain |
| Equitable | 18,866 | 0 | 0 | 0 | For |
| Invesco | 17,995 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,300 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,112 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 13,761 | 0 | Abstain |
| Pacific Life | 10,772 | 0 | 0 | 0 | For |
| GPS Funds I | 9,445 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,442 | 0 | 0 | 0 | For |
| Brighthouse | 7,920 | 0 | 0 | 0 | For |
| John Hancock | 5,678 | 0 | 0 | 0 | For |
| ProShares | 4,388 | 0 | 0 | 0 | For |
| Voya | 4,320 | 0 | 0 | 0 | For |
| DWS | 4,135 | 0 | 0 | 0 | For |
| State Street | 2,673 | 0 | 0 | 0 | For |
| Nationwide | 2,206 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 0 | 0 | 1,942 | 0 | Abstain |
| SEI | 0 | 0 | 1,800 | 0 | Abstain |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Fennec Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Dr. Khalid Islam”): 20,246,596 for, 126,891 withheld, per its Form 8-K filed 2026-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 34,737,030 outstanding shares: 58% for, 0.4% withheld (59% of the company cast a for/withheld vote).
The 34 asset managers below cast 100% of the shares they voted on this item FOR (2,368,042 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,052,649 | 0 | 0 | 0 | For |
| BlackRock | 572,407 | 0 | 0 | 0 | For |
| Fidelity | 337,719 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 108,005 | 0 | 0 | 0 | For |
| Charles Schwab | 63,537 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 33,481 | 0 | 0 | 0 | For |
| Eleva Capital SAS | 24,960 | 0 | 0 | 0 | For |
| TIAA | 23,524 | 0 | 0 | 0 | For |
| Equitable | 18,866 | 0 | 0 | 0 | For |
| Invesco | 17,995 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,300 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,112 | 0 | 0 | 0 | For |
| Global X | 13,761 | 0 | 0 | 0 | For |
| Pacific Life | 10,772 | 0 | 0 | 0 | For |
| GPS Funds I | 9,445 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,442 | 0 | 0 | 0 | For |
| Brighthouse | 7,920 | 0 | 0 | 0 | For |
| John Hancock | 5,678 | 0 | 0 | 0 | For |
| ProShares | 4,388 | 0 | 0 | 0 | For |
| Voya | 4,320 | 0 | 0 | 0 | For |
| DWS | 4,135 | 0 | 0 | 0 | For |
| State Street | 2,673 | 0 | 0 | 0 | For |
| Nationwide | 2,206 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 1,942 | 0 | 0 | 0 | For |
| SEI | 1,800 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Fennec Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Marco Brughera”): 20,237,230 for, 136,257 withheld, per its Form 8-K filed 2026-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 34,737,030 outstanding shares: 58% for, 0.4% withheld (59% of the company cast a for/withheld vote).
The 34 asset managers below cast 100% of the shares they voted on this item FOR (2,344,518 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,052,649 | 0 | 0 | 0 | For |
| BlackRock | 572,407 | 0 | 0 | 0 | For |
| Fidelity | 337,719 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 108,005 | 0 | 0 | 0 | For |
| Charles Schwab | 63,537 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 33,481 | 0 | 0 | 0 | For |
| Eleva Capital SAS | 24,960 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 23,524 | 0 | Abstain |
| Equitable | 18,866 | 0 | 0 | 0 | For |
| Invesco | 17,995 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,300 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,112 | 0 | 0 | 0 | For |
| Global X | 13,761 | 0 | 0 | 0 | For |
| Pacific Life | 10,772 | 0 | 0 | 0 | For |
| GPS Funds I | 9,445 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,442 | 0 | 0 | 0 | For |
| Brighthouse | 7,920 | 0 | 0 | 0 | For |
| John Hancock | 5,678 | 0 | 0 | 0 | For |
| ProShares | 4,388 | 0 | 0 | 0 | For |
| Voya | 4,320 | 0 | 0 | 0 | For |
| DWS | 4,135 | 0 | 0 | 0 | For |
| State Street | 2,673 | 0 | 0 | 0 | For |
| Nationwide | 2,206 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 1,942 | 0 | 0 | 0 | For |
| SEI | 1,800 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Fennec Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Chris A. Rallis”): 20,126,058 for, 247,429 withheld, per its Form 8-K filed 2026-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 34,737,030 outstanding shares: 58% for, 0.8% withheld (59% of the company cast a for/withheld vote).
The 34 asset managers below cast 100% of the shares they voted on this item FOR (2,344,518 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,052,649 | 0 | 0 | 0 | For |
| BlackRock | 572,407 | 0 | 0 | 0 | For |
| Fidelity | 337,719 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 108,005 | 0 | 0 | 0 | For |
| Charles Schwab | 63,537 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 33,481 | 0 | 0 | 0 | For |
| Eleva Capital SAS | 24,960 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 23,524 | 0 | Abstain |
| Equitable | 18,866 | 0 | 0 | 0 | For |
| Invesco | 17,995 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,300 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,112 | 0 | 0 | 0 | For |
| Global X | 13,761 | 0 | 0 | 0 | For |
| Pacific Life | 10,772 | 0 | 0 | 0 | For |
| GPS Funds I | 9,445 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,442 | 0 | 0 | 0 | For |
| Brighthouse | 7,920 | 0 | 0 | 0 | For |
| John Hancock | 5,678 | 0 | 0 | 0 | For |
| ProShares | 4,388 | 0 | 0 | 0 | For |
| Voya | 4,320 | 0 | 0 | 0 | For |
| DWS | 4,135 | 0 | 0 | 0 | For |
| State Street | 2,673 | 0 | 0 | 0 | For |
| Nationwide | 2,206 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 1,942 | 0 | 0 | 0 | For |
| SEI | 1,800 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Fennec Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Jeffrey Hackman”): 20,282,707 for, 90,780 withheld, per its Form 8-K filed 2026-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 34,737,030 outstanding shares: 58% for, 0.3% withheld (59% of the company cast a for/withheld vote).
The 34 asset managers below cast 100% of the shares they voted on this item FOR (2,369,541 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,052,649 | 0 | 0 | 0 | For |
| BlackRock | 572,407 | 0 | 0 | 0 | For |
| Fidelity | 337,719 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 108,005 | 0 | 0 | 0 | For |
| Charles Schwab | 63,537 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 33,481 | 0 | 0 | 0 | For |
| Eleva Capital SAS | 24,960 | 0 | 0 | 0 | For |
| TIAA | 23,524 | 0 | 0 | 0 | For |
| Equitable | 18,866 | 0 | 0 | 0 | For |
| Invesco | 17,995 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,300 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,112 | 0 | 0 | 0 | For |
| Global X | 13,761 | 0 | 0 | 0 | For |
| Pacific Life | 10,772 | 0 | 0 | 0 | For |
| GPS Funds I | 9,445 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,442 | 0 | 0 | 0 | For |
| Brighthouse | 7,920 | 0 | 0 | 0 | For |
| John Hancock | 5,678 | 0 | 0 | 0 | For |
| ProShares | 4,388 | 0 | 0 | 0 | For |
| Voya | 4,320 | 0 | 0 | 0 | For |
| DWS | 4,135 | 0 | 0 | 0 | For |
| State Street | 2,673 | 0 | 0 | 0 | For |
| Nationwide | 2,206 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 1,942 | 0 | 0 | 0 | For |
| SEI | 1,800 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Combines 2 wordings of this item as funds reported it.
95% Passed · of votes cast
Fennec Pharmaceuticals Inc.’s own tally for this item (“Proposal 6: The resolution to ratify and approve the adoption of Fennec's 2026 Equity Inducement Plan was approved based on the following vote:.”): 18,626,207 for, 1,033,779 against — passed, per its Form 8-K filed 2026-06-10 (Item 5.07). Of all 34,737,030 outstanding shares: 53.6% for, 3% against (57% of the company cast a for/against vote).
The 33 asset managers below cast 91% of the shares they voted on this item FOR (2,136,766 for, 207,815 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,052,649 | 0 | 0 | 0 | For |
| BlackRock | 572,407 | 0 | 0 | 0 | For |
| Fidelity | 337,719 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 108,005 | 0 | 0 | Against |
| Charles Schwab | 63,537 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 33,481 | 0 | 0 | 0 | For |
| TIAA | 23,524 | 0 | 0 | 0 | For |
| Equitable | 13,526 | 5,340 | 0 | 0 | For |
| Invesco | 0 | 17,995 | 0 | 0 | Against |
| Lincoln Financial | 0 | 17,300 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 14,112 | 0 | 0 | Against |
| Global X | 13,761 | 0 | 0 | 0 | For |
| Pacific Life | 10,772 | 0 | 0 | 0 | For |
| GPS Funds I | 0 | 9,445 | 0 | 0 | Against |
| Bridge Builder Trust | 9,442 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 7,920 | 0 | 0 | Against |
| John Hancock | 0 | 5,678 | 0 | 0 | Against |
| ProShares | 0 | 4,388 | 0 | 0 | Against |
| Voya | 0 | 4,320 | 0 | 0 | Against |
| DWS | 0 | 4,135 | 0 | 0 | Against |
| State Street | 0 | 2,673 | 0 | 0 | Against |
| Nationwide | 2,206 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 1,942 | 0 | 0 | 0 | For |
| SEI | 1,800 | 0 | 0 | 0 | For |
| Franklin Templeton | 0 | 1,562 | 0 | 0 | Against |
Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.
Combines 2 wordings of this item as funds reported it.
92% Passed · of votes cast
Fennec Pharmaceuticals Inc.’s own tally for this item (“Proposal 5: The resolution to approve certain amendments to Corporation's 2020 Equity Incentive Plan was approved based on the following vote:”): 17,425,439 for, 1,429,951 against — passed, per its Form 8-K filed 2026-06-10 (Item 5.07). Of all 34,737,030 outstanding shares: 50.2% for, 4% against (54.3% of the company cast a for/against vote).
The 33 asset managers below cast 91% of the shares they voted on this item FOR (2,136,766 for, 207,815 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,052,649 | 0 | 0 | 0 | For |
| BlackRock | 572,407 | 0 | 0 | 0 | For |
| Fidelity | 337,719 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 108,005 | 0 | 0 | Against |
| Charles Schwab | 63,537 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 33,481 | 0 | 0 | 0 | For |
| TIAA | 23,524 | 0 | 0 | 0 | For |
| Equitable | 13,526 | 5,340 | 0 | 0 | For |
| Invesco | 0 | 17,995 | 0 | 0 | Against |
| Lincoln Financial | 0 | 17,300 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 14,112 | 0 | 0 | Against |
| Global X | 13,761 | 0 | 0 | 0 | For |
| Pacific Life | 10,772 | 0 | 0 | 0 | For |
| GPS Funds I | 0 | 9,445 | 0 | 0 | Against |
| Bridge Builder Trust | 9,442 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 7,920 | 0 | 0 | Against |
| John Hancock | 0 | 5,678 | 0 | 0 | Against |
| ProShares | 0 | 4,388 | 0 | 0 | Against |
| Voya | 0 | 4,320 | 0 | 0 | Against |
| DWS | 0 | 4,135 | 0 | 0 | Against |
| State Street | 0 | 2,673 | 0 | 0 | Against |
| Nationwide | 2,206 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 1,942 | 0 | 0 | 0 | For |
| SEI | 1,800 | 0 | 0 | 0 | For |
| Franklin Templeton | 0 | 1,562 | 0 | 0 | Against |
Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.
99.9% fund support · no official result
The 15 asset managers below cast 99.9% of the shares they voted on this item FOR (179,796 for, 46 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Charles Schwab | 127,074 | 0 | 0 | 0 | For |
| Global X | 13,761 | 0 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 9,753 | 0 | 0 | 0 | For |
| WASHINGTON STATE INVESTMENT BOARD | 8,236 | 0 | 0 | 0 | For |
| SEI | 7,262 | 0 | 0 | 0 | For |
| Prudential/PGIM | 4,070 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 3,186 | 0 | 0 | 0 | For |
| Russell Investments | 1,942 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 1,942 | 0 | 0 | 0 | For |
| Federated Hermes | 1,517 | 0 | 0 | 0 | For |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 539 | 0 | 0 | 0 | For |
| Neuberger Berman | 181 | 0 | 0 | 0 | For |
| YOUSIF CAPITAL MANAGEMENT, LLC | 170 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 163 | 0 | 0 | 0 | For |
| NISA INVESTMENT ADVISORS, LLC | 0 | 46 | 0 | 0 | Against |
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (24,989 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Eleva Capital SAS | 24,960 | 0 | 0 | 0 | For |
| TD Waterhouse Canada Inc. | 29 | 0 | 0 | 0 | For |
Ranked by the number of Fennec Pharmaceuticals Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 34,737,030 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Southpoint Capital Advisors LP | 7.90% |
| 2 | Solas Capital Management, LLC | 7.15% |
| 3 | AIGH Capital Management LLC | 5.85% |
| 4 | Vanguard | 3.16% |
| 5 | BlackRock | 2.62% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.08% |
| 7 | Fidelity | 0.99% |
| 8 | State Street | 0.61% |
| 9 | PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0.43% |
| 10 | Charles Schwab | 0.37% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Kam Lawrence | 8.06% | 13G |
| AIGH Capital Management LLC | 5.70% | 13G |
| BlackRock | 3.94% | 13F |
| Vanguard Group | 3.07% | 13F |
| Geode Capital | 1.07% | 13F |
| State Street | 1.03% | 13F |
| Morgan Stanley | 0.70% | 13F |
| Citadel Advisors | 0.44% | 13F |
| Northern Trust | 0.44% | 13F |
| Charles Schwab | 0.18% | 13F |
Percentages above are of 34,737,030 shares outstanding, as reported by Fennec Pharmaceuticals Inc. on its Form 10-Q dated 2026-05-12 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Fennec Pharmaceuticals Inc.’s 10-Q dated 2026-05-12. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.
At Fennec Pharmaceuticals Inc.'s shareholder meeting held 2026-06-10, in the 2025-2026 proxy season, 102 asset managers reported how they voted in their SEC Form N-PX filings, covering 967 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — ADVISORY VOTE To vote, on an advisory (non-binding) basis, on the frequency of advisory votes… — Fennec Pharmaceuticals Inc. reported that the proposal passed. No complete for/against tally from that filing is on record here, so no support percentage is given for it. Source: Fennec Pharmaceuticals Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-10.
Fennec Pharmaceuticals Inc. proxy season coverage: 2025-2026 (this page).